NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Tuesday a 28 percent rise in first quarter revenues, an increase helped by the placement of 22 of its XT-8 molecular diagnostic systems during the period.

For the three-month period ended March 31, GenMark's revenues rose to $10.1 million from $7.9 million in the same period a year earlier, in line with the average Wall Street estimate.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.